$100 Million is the total value of Versant Venture Management, LLC's 10 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | $31,294,000 | -17.2% | 498,558 | 0.0% | 31.24% | +54.6% | |
| PASG | Passage Bio, Inc. | $15,375,000 | -51.2% | 4,959,769 | 0.0% | 15.35% | -8.9% | |
| GRTS | Gritstone Oncology, Inc. | $14,672,000 | -68.0% | 3,561,150 | 0.0% | 14.65% | -40.2% | |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9,007,000 | -22.7% | 410,360 | 0.0% | 8.99% | +44.2% | |
| AKRO | Akero Therapeutics, Inc. | $8,766,000 | -32.9% | 617,727 | 0.0% | 8.75% | +25.2% | |
| Minerva Surgical Inc. | $7,532,000 | -12.4% | 1,673,700 | 0.0% | 7.52% | +63.4% | ||
| ADVM | Adverum Biotechnologies, Inc. | $6,639,000 | -25.6% | 5,068,233 | 0.0% | 6.63% | +38.9% | |
| ALGS | Aligos Therapeutics, Inc. | $4,989,000 | -81.9% | 2,320,381 | 0.0% | 4.98% | -66.2% | |
| CBAY | CymaBay Therapeutics, Inc. | $1,691,000 | -8.0% | 543,753 | 0.0% | 1.69% | +71.7% | |
| CLVS | Clovis Oncology, Inc. | $206,000 | -25.4% | 101,855 | 0.0% | 0.21% | +39.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CymaBay Therapeutics, Inc. | 35 | Q2 2023 | 10.2% |
| Clovis Oncology, Inc. | 32 | Q3 2022 | 53.2% |
| CRISPR Therapeutics AG | 23 | Q3 2023 | 77.2% |
| Ocular Therapeutix, Inc. | 22 | Q4 2020 | 18.0% |
| Gritstone Oncology, Inc. | 18 | Q3 2023 | 25.4% |
| Achaogen, Inc. | 18 | Q1 2019 | 23.5% |
| Adverum Biotechnologies, Inc. | 15 | Q3 2023 | 21.0% |
| Second Sight Medical Products, Inc. | 15 | Q3 2020 | 9.0% |
| Audentes Therapeutics, Inc. | 13 | Q3 2019 | 39.6% |
| Aligos Therapeutics, Inc. | 12 | Q3 2023 | 15.7% |
View Versant Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-08 |
| 13F-HR | 2023-11-03 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-11 |
| 144 | 2023-04-20 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-11 |
View Versant Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.